释放氧化的血液透析导管锁解决方案
Sara E Maloney1, Quincy E Grayton1, Christine Wai2
1Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
ACS applied materials & interfaces
|June 7, 2023
概括
新的释放氧化 (NO) 的透析导管锁解决方案可以防止细菌粘附,减少感染和血栓形成. 这些无释放的解决方案为改善道透析导管 (TDC) 功能和患者结果提供了一个有希望的策略.
科学领域:
- 生物材料科学 生物材料科学
- 传染病研究 传染病研究
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 道式透析导管 (TDC) 对于血液透析至关重要,但容易出现功能障碍,导致严重的发病率,死亡率和经济成本.
- 导管相关的血流感染和血栓形成是与TDC使用相关的主要并发症.
研究的目的:
- 为TDCs开发和评估释放氧化 (NO) 的新型导管锁解决方案.
- 评估这些无释放溶液在预防细菌粘附,蛋白质污染和血栓形成方面的有效性,并评估它们的安全性和体内性能.
主要方法:
- 使用具有不同释放动态的低分子量N-diazeniumdiolateNO捐赠体制备释放NO的锁定溶液.
- 在体外评估NO释放时间,细菌粘附抑制 (Pseudomonas aeruginosa,Staphylococcus epidermidis),蛋白质粘附和细胞毒性.
- 在猪模型中的体内评估,使用带有NO释放锁定溶液的TDC来评估感染,血栓形成,导管功能和生存率.
主要成果:
- 从锁定溶液中持续释放的NO维持了治疗水平超过72小时.
- 缓慢,持续的NO释放显著抑制了细菌粘附 (88.9-99.7%),并减少了现有的细菌粘附 (98.7-99.2%).
- 蛋白质粘附率降低了60-65%,体内研究显示感染,血栓形成减少,导管功能和存活率改善.
结论:
- 不释放NO的透析导管锁解决方案显示出强大的抗微生物和抗血栓性质.
- 这些解决方案具有最小的细胞毒性,并显示出改善TDC寿命和血液透析患者结果的显著前景.
- 这一发展代表了预防和治疗TDC相关并发症的可转化进步.
相关概念视频
01:24Hemodialysis II: Procedure and Complications
42
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
42
01:25Hemodialysis I: Introduction
70
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
70
01:23Antihypertensive Drugs: Vasodilators
581
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
581
01:15Dialysis
737
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
737
01:25Hemodialysis III: Nursing Management
50
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
50
01:30Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54